The overall goal of this program is to define mechanisms that regulate cerebral blood vessels under normal and pathophysiological conditions. The program has successfully integrated emer4ging molecular techniques with more traditional physiological approaches to examine mechanisms that regulate structure and function of the cerebral circulation under normal and pathophysiological conditions. This evolution within the program continues with this renewal as new approaches and investigators continue to be incorporated. The program has several well-defined themes: First, protective mechanisms [nitric oxide, superoxide dismutase (SOD)], and peroxisome proliferator activated receptor (PPAR) in cerebral blood vessels. Second, sources of superoxide within the vessel wall [NAD(P)H oxidase and cyclooxygenase (COX)] and the role of the major cell types-endothelium, smooth muscle, and adventita. Third, pathophysiology and risk factors for cerebral vascular disease and stroke. Modern molecular and mechanistic approaches are used to examine effects of chronic hypertension, diabetes, hypercholesterolemia, hyperhomocysteinemia, and inflammation on cerebral vascular structure and function. The Program has several strengths. First, the investigators have a long, productive history of studies of cerebral circulation under physiological and pathophysiological conditions. Second, strong new investigators with key expertise have been integrated into the program. Third, the investigators use diverse, cutting edge approaches altered mice and viral mediated gene transfer, were successfully incorporated during the last funding period and continue to be used heavily. Fourth, the investigators are leaders in several areas of study of the cerebral circulation (endothelial cell biology, nitric oxide, potassium channels, vascular structure) as well as leaders in studies of the impact of cardiovascular risk factors on cerebral vascular biology. The program consists of four projects supported by two core facilities: Administration and Transgenic Animal Core. This integrated, multi- disciplinary approach is intended to facilitate, rapid progress, and more penetrating insight, in understanding mechanisms that regulate cerebral vascular structure and function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
2P01NS024621-16
Application #
6467282
Study Section
Special Emphasis Panel (ZNS1-SRB-K (02))
Program Officer
Jacobs, Tom P
Project Start
1987-04-01
Project End
2007-05-31
Budget Start
2002-06-01
Budget End
2003-05-31
Support Year
16
Fiscal Year
2002
Total Cost
$1,274,031
Indirect Cost
Name
University of Iowa
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Ketsawatsomkron, Pimonrat; Keen, Henry L; Davis, Deborah R et al. (2016) Protective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-? Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension. Hypertension 67:214-22
Dayal, Sanjana; Gu, Sean X; Hutchins, Ryan D et al. (2015) Deficiency of superoxide dismutase impairs protein C activation and enhances susceptibility to experimental thrombosis. Arterioscler Thromb Vasc Biol 35:1798-804
Rodionov, Roman N; Jarzebska, Natalia; Weiss, Norbert et al. (2014) AGXT2: a promiscuous aminotransferase. Trends Pharmacol Sci 35:575-82
De Silva, T Michael; Modrick, Mary L; Ketsawatsomkron, Pimonrat et al. (2014) Role of peroxisome proliferator-activated receptor-? in vascular muscle in the cerebral circulation. Hypertension 64:1088-93
Chrissobolis, Sophocles; Drummond, Grant R; Faraci, Frank M et al. (2014) Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation. J Hypertens 32:1815-21
Johnson, Andrew W; Kinzenbaw, Dale A; Modrick, Mary L et al. (2013) Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension. Hypertension 61:437-42
Chu, Yi; Lund, Donald D; Weiss, Robert M et al. (2013) Pioglitazone attenuates valvular calcification induced by hypercholesterolemia. Arterioscler Thromb Vasc Biol 33:523-32
Klykov, Corinne M; Lentz, Steven R (2013) Trends in clinical laboratory homocysteine testing from 1997 to 2010: the impact of evidence on clinical practice at a single institution. Clin Chem Lab Med 51:671-5
Dayal, Sanjana; Wilson, Katina M; Motto, David G et al. (2013) Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis. Circulation 127:1308-16
Miller, Jordan D; Chu, Yi; Castaneda, Lauren E et al. (2013) Vascular function during prolonged progression and regression of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 33:459-65

Showing the most recent 10 out of 432 publications